News & Press Releases

New Haven biotech honored for work developing cancer-fighting drugs

Finding a cure for cancer is personal for many working at Kleo Pharmaceuticals in New Haven.

Doug Manion, MD, the company’s CEO, has lost friends and family to the disease, as has the company’s co-founder, David Spiegel, MD.

Kleo is an immuno-oncology company working to develop medication that boosts the body’s immune system. The idea, according to Manion, is to turbocharge the immune system so it can rid itself of cancer — a more natural approach than traditional therapies like chemotherapy.

Read Full Article

Print Friendly, PDF & Email

Reader Interactions

Upcoming Events:

No event found!